PATENT CLAIM ANALYSIS

Application Number: 15922581
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "047000"]

Abstract:
The present invention discloses compounds of formula (I): which exhibit antiviral properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of anti-HBV treatment. The invention also relates to methods of treating a HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Claim (Index 11):
The method of  claim 10 , wherein the alkylating agent is iodomethyl isopropyl carbonate.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.65
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14939397', '13296221', '11637520', '14823359', '12897389']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7620187427916324
- 35 USC 102 Novelty (BERT): 0.5411355077448639
- Combined Prediction Score: 0.7399304192869556
- Mean Citation Score: 299.883796
- Max Citation Score: 360.72437
- Similarity Product: 228.80798157205825

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test